Abstract
Objectives
The purpose of this study was to introduce a modified transjugular intrahepatic portosystemic shunt (TIPS), a percutaneous transhepatic intrahepatic portosystemic shunt (PTIPS), and to evaluate its feasibility and efficacy in patients with variceal bleeding with chronic portal vein occlusion (CPVO) after splenectomy.
Methods
Twenty-four cirrhotic patients with CPVO after splenectomy who received PTIPS between 2010 and 2015 were included in this retrospective study. The indication was elective control of variceal bleeding. Success rates, effectiveness and complications were evaluated, with comparison of the pre- and post-portosystemic pressure gradient (PPG). Patients’ clinical outcomes and shunt patency were followed periodically.
Results
PTIPS was successfully placed in 22 patients (91.7%) and failed in two. The mean PPG fell from 22.0 ± 4.9 mmHg to 10.6 ± 1.6 mmHg after successful PTIPS (p < 0.05). No fatal procedural complications occurred. During the median follow-up of 29 months, shunt dysfunction occurred in five cases and hepatic encephalopathy in four cases. Three patients died because of rebleeding, hepatic failure and pulmonary disease, respectively. The other patients remained asymptomatic and the shunts patent.
Conclusions
We conclude that PTIPS, as a modified TIPS procedure with a high success rate, is safe and effective for variceal bleeding with CPVO after splenectomy.
Key Points
• Portal vein occlusion used to be contraindication to transjugular intrahepatic portosystemic shunt.
• Portal vein thrombosis is common in patients with previous splenectomy.
• We developed a new method, percutaneous transhepatic intrahepatic portosystemic shunt (PTIPS).
• PTIPS is feasible in patients with portal vein thrombosis and splenectomy.
• PTIPS is effective and safe for these kind of complicated portal hypertension.
Similar content being viewed by others
Abbreviations
- CPVO:
-
Chronic portal vein occlusion
- PPG:
-
Portosystemic pressure gradient
- PTIPS:
-
Percutaneous transhepatic intrahepatic portosystemic shunt
- PVT:
-
Portal vein thrombosis
References
Cheng LF, Jia JD, Xu XY et al (2009) Esophagogastric variceal bleeding in cirrhotic portal hypertension: consensus on prevention and management (2008). Chin Med J (Engl) 122:766–775
Yang Z, Qiu F (2000) Pericardial devascularization with splenectomy for the treatment of portal hypertension. Chin J Surg 38:645–648
Qi X, Han G, Ye C et al (2016) Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients. Med Sci Monit 22:2528–2550
European Association for the Study of the Liver (2016) EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol 64:179–202
Rodríguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M (2012) Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 94:1145–1153
Bauer J, Johnson SJ, Ludkowski M et al (2006) The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl 12:1544–1551
Jiang ZB, Shan H, Shen XY et al (2004) Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol 10:1881–1884
Radosevich PM, Ring EJ, Laberge JM et al (1993) Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 186:523–527
Blum U, Haag K, Rössle M et al (1995) Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis. Radiology 195:153–157
Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D (2006) Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 23:767–775
Van Ha TG, Hodge J, Funaki B et al (2006) Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Intervent Radiol 29:785–790
Wils A, van der Linden E, van Hoek B, Pattynama PM (2009) Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation. J Clin Gastroenterol 43:982–984
Streitparth F, Santosa F, Milz J et al (2008) Transjugular intrahepatic portosystemic shunt in patients with portal vein thrombosis. Rofo 180:899–905
Han GH, Meng XJ, Yin ZX et al (2009) Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation. Zhonghua Yi Xue Za Zhi 89:1549–1552
Chen Y, Ye P, Li Y, Ma S, Zhao J, Zeng Q (2015) Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Eur Radiol 25:3431–3437
Salem R, Vouche M, Baker T et al (2015) Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis. Transplantation 99:2347–2355
Habib A, Desai K, Hickey R et al (2015) Portal vein recanalization–transjugular intrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol 26:499–506
Qi X, Han G, He C et al (2012) Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: A hypothesis. Med Sci Monit 18:37–41
Garcia-Pagán JC, Hernández-Guerra M, Bosch J (2008) Extrahepatic portal vein thrombosis. Semin Liver Dis 28:282–292
Wang Z, Zhao H, Wang X et al (2015) Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis. Abdom Imaging 40:1813–1820
Holster IL, Tjwa ET, Moelker A et al (2016) Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding. Hepatology 63:581–589
Haskal ZJ, Duszak R Jr, Furth EE (1996) Transjugular intrahepatic transcaval portosystemic shunt: The gun-sight approach. J Vasc Interv Radiol 7:139–142
Leong S, Hong KK, Govender P, Torreggiani W (2013) Reducing risk of transjugular intrahepatic portosystemic shunt using ultrasound guided single needle pass. World J Gastroenterol 19:3528–3530
Delgado MG, Seijo S, Yepes I et al (2012) Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 10:776–783
Chung JW, Kim GH, Lee JH et al (2014) Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis. Clin Mol Hepatol 20:384–391
Chen H, Liu L, Qi X et al (2016) Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 28:82–89
Wang Z, Jiang MS, Zhang HL et al (2016) Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial. Radiology 279:943–951
Boyer TD, Haskal ZJ (2010) The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 51:386–400
Krajina A, Hulek P, Fejfar T, Valek V (2012) Quality improvement guidelines for transjugular intrahepatic portosystemic shunt (TIPS). Cardiovasc Interv Radiol 35:1295–1300
Qi X, Han G (2012) Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int 6:576–590
Funding
This study has received funding from the Science and Technology Planning Project of Guangdong Province, China, No. 2012B031800085.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Zaibo Jiang.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was obtained from all subjects (patients) in this study.
Ethical approval
Institutional review board approval was obtained.
Study subjects or cohorts overlap
Some study subjects (including one overlap patient) were previously reported by Li MA et al. (Zhonghua Yi Xue Za Zhi 92:2913-2917, 2012).
Methodology
• retrospective
• performed at one institution
Additional information
Junyang Luo and Mingan Li share first authorship.
Rights and permissions
About this article
Cite this article
Luo, J., Li, M., Zhang, Y. et al. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy. Eur Radiol 28, 3661–3668 (2018). https://doi.org/10.1007/s00330-018-5360-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-018-5360-z